Surgery Partners Market Sentiment

Surgery Partners Inc

SGRYNASDAQ

Trade with Public

$15.19

-0.13-0.85%

At close: Aug 13, 5:00 PM EST

$15.21

0.020.13%

After Hours: 4:00 PM EST

Earnings: Q2 2026 Earnings were released on Mon Aug 10th, before the market open

Conference Call: The most recent conference call started at 8:30 AM, 4 days ago

Click to view the webcast

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Surgery Partners Market Sentiment

Market sentiment signals for Surgery Partners (SGRY): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 20.5% short float

Options Flow▲ 0.00 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

13 analysts

Options Flow (P/C)

0.00

More calls — Bullish

33 calls · 0 puts

Avg Consensus PT

$24

+58.9%

Highest Price Target

$36

+136.7%

Citigroup

Lowest Price Target

$14

-8.0%

Barclays

Short Interest

20.5%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 11, 2026	TD Cowen	Ryan Langston—	+24.9%	$17 → $19	Maintained	Buy
Aug 11, 2026	RBC Capital	Ben Hendrix—	+24.9%	$20 → $19	Maintained	Outperform
Aug 11, 2026	Cantor Fitzgerald	Sarah James—	+18.3%	$18 → $18	Maintained	Overweight
Mar 5, 2026	TD Cowen	Ryan Langston—	+31.5%	$28 → $20	Maintained	Buy
Mar 5, 2026	UBS	A.J. Rice—	+38.1%	$29 → $21	Maintained	Buy
Mar 5, 2026	Mizuho	Ann Hynes—	+11.8%	$19 → $17	Maintained	Outperform
Mar 4, 2026	RBC Capital	Ben Hendrix—	+31.5%	$31 → $20	Maintained	Outperform
Mar 3, 2026	Barclays	Andrew Mok—	-8.0%	$18 → $14	Maintained	Equal-Weight
Dec 18, 2025	Mizuho	Ann Hynes—	+24.9%	$22 → $19	Maintained	Outperform
Nov 24, 2025	JP Morgan	Benjamin Rossi—	+31.5%	$27 → $20	Maintained	Neutral
Nov 21, 2025	Barclays	Andrew Mok—	+18.3%	$24 → $18	Maintained	Equal-Weight
Nov 17, 2025	Mizuho	Ann Hynes—	+44.6%	$28 → $22	Maintained	Outperform
Nov 13, 2025	UBS	A.J. Rice—	+90.7%	$34 → $29	Maintained	Buy
Nov 11, 2025	RBC Capital	Ben Hendrix—	+103.8%	$35 → $31	Maintained	Outperform
Nov 11, 2025	Benchmark	Bill Sutherland—	+97.2%	$35 → $30	Maintained	Buy
Oct 7, 2025	Cantor Fitzgerald	Sarah James—	+136.7%	$36 → $36	Maintained	Overweight
Sep 18, 2025	JP Morgan	Benjamin Rossi—	+77.5%	$27	Assumes	Neutral
May 27, 2025	Barclays	Andrew Mok—	+57.8%	$25 → $24	Maintained	Equal-Weight
Apr 21, 2025	Benchmark	Bill Sutherland—	+130.1%	$35 → $35	Maintained	Buy
Mar 25, 2025	RBC Capital	Ben Hendrix—	+130.1%	$35 → $35	Maintained	Outperform
Mar 11, 2025	Macquarie	Tao Qiu—	+117.0%	$34 → $33	Maintained	Outperform
Dec 3, 2024	JP Morgan	Lisa Gill—	+84.1%	$38 → $28	Maintained	Neutral
Nov 20, 2024	RBC Capital	Ben Hendrix—	+130.1%	$49 → $35	Maintained	Outperform
Nov 19, 2024	Macquarie	Tao Qiu—	+123.5%	$34 → $34	Maintained	Outperform
Nov 14, 2024	Barclays	Andrew Mok—	+103.8%	$32 → $31	Maintained	Equal-Weight